G3BP1通过cGAS调控抗病毒天然免疫的作用机制研究
[Abstract]:The natural immune system is the first line of defense against the invasion of pathogenic microorganisms. When the microorganisms invade the body, the natural immune cells can quickly identify and activate the corresponding immune response, promote the immune system to kill and clear the invading pathogenic microorganisms. This recognition process is achieved primarily by pattern recognition receptors (PRRs) located within a cell membrane or cell, which can identify highly conserved molecular structures common to certain pathogenic microorganisms, such as proteins, nucleic acids, lipoproteins, lipopolysaccharides, and the like, Referred to as the pathogen-related molecular pattern (PMPs). The PRRs currently known mainly include the TLRs (Toll-like receptors) family, the NLRs (NOD-like receptors) family, the CLRs (C-type lectins) family, the RLRs (RIG-I-like receptors) family and some of the cytoplasmic DNA receptors, wherein the DNA receptors are a class of important PRRs that recognize the cytoplasmic DNA and play an important role in the anti-viral immune response. Normally, the DNA is present only in the nucleus and mitochondria of the eukaryotic cells. The presence of free DNA in the cytoplasm at the time of viral infection or cell damage is an important PAMP. These DNA are recognized and activated by intracellular DNA receptors and play an important role in the anti-viral immunity of the body. CGAS is an intracellular DNA receptor that was identified in 2013 and is believed to be the most important receptor for identifying the cytoplasmic DNA, which plays an important role in the cytoplasmic DNA-induced interferon pathway, and the overexpression of cGAS-mediated signaling pathways is closely related to a variety of autoimmune diseases. At present, little is known about the regulation and control of the signal path of the cGAS, and a new key control factor for the signal path is found, so that the regulation mechanism of the anti-viral natural immune response of the organism can be deeply recognized, and a new target point and a strategy are also provided for the treatment of an autoimmune disease. The interaction protein G3BP1 (GTPase-activating protein-(SH3domain)-binding protein 1) was identified by mass spectrometry. G3BP1 has a nucleic acid binding capacity. G3BP1 is known to be able to initiate the assembly of a complex-stress particle (SGs) consisting of a variety of proteins and mRNAs, thereby having an important role in cell antiviral immunity, in particular in anti-RNA viral immunity. However, whether G3BP1 is involved in the cellular DNA-induced immune response has not been reported. In order to study the role of G3BP1 in the cytoplasmic DNA-induced interferon pathway, the G3bp1 knockout cell line was first constructed using the CRISPR/ Cas9 technique. The knockout of G3bp1 could significantly inhibit the activation of the signaling pathway and the production of type I interferon, which indicated that G3BP1 had an important positive control in the DNA-induced type I interferon pathway. cGAS, as a nuclear transfer enzyme, can change in conformation after identification and binding to the cytoplasm DNA, and rapidly catalyze ATP and GTP to form the second messenger cGGAMP (Cyclic GMP-AMP) of the small molecule, thereby activating the terminal protein STRING and the downstream signal path, causing the transcription factor IRF3 (Interferon-region factor 3) to be activated, Start the expression of type I interferon. Using cGAMP to stimulate the cells, we found that the absence of G3BP1 did not affect the activation of the signal pathway induced by cGAMP, suggesting that the regulatory effect of G3BP1 on the DNA-induced type I interferon pathway may be achieved by modulating the cGAAS function. CGAMP is the product of cGAS, and its synthetic quantity directly indicates the activity of cGAS. We use the LC-MS/ MRM (Liquid chromatography-mass spectrometry with multiple-action monitoring) to directly detect the amount of cGAMP induced by the cytoplasmic DNA. The results show that the G3BP1 deletion significantly affects the synthesis of cGAMP, and it is proved that the regulation of G3BP1 on cGAS is realized by the effect of the function of cGAS. It is known that G3BP1 is capable of partially dissociating double-stranded DNA and double-stranded RNA, so that G3BP1 may be involved in the process of recognizing DNA by cGAS. We constructed a DNA-binding experiment system, and found that the deletion of G3BP1 significantly reduced the binding capacity of cGAS to DNA. This demonstrates that G3BP1 is produced by the regulation of DNA-induced type I interferon by influencing the DNA binding ability of cGAS. In the case of a DNA-infected cell, the self-DNA is injected into the cell for replication and protein expression. These DNA will also be identified by the cytoplasmic DNA receptors, activate the interferon pathway, and initiate antiviral effects. In order to study the role of G3BP1 in the anti-DNA virus immune response, we used the DNA virus HSV1 (Hades simplex virus 1) to infect the cells and detect the production of type I interferon and the replication of the virus, and it was found that the deletion of G3BP1 clearly inhibited the production of type I interferon induced by the DNA virus, at the same time, The detection of HSV1 mRNA and virus titer showed that the replication ability of HSV1 was significantly enhanced in the G3BP1-deficient cells, suggesting that G3BP1 had an important role in the immune response of the anti-DNA virus. In this study, we identified a new functional regulatory molecule G3BP1 in a cytoplasmic DNA recognition signal pathway and explained the important role of G3BP1 in the anti-DNA virus infection by regulating the molecular mechanism of the DNA binding ability of cGAS to affect its function. G3BP1 is known to play an important role in the immune response of the virus, in particular the RNA virus, by SGs. Our study found that G3BP1 plays a key role in the immune response induced by DNA virus by regulating the function of cGAS to affect the production of type I interferon. The results provide a new experimental basis for the in-depth understanding of the function and regulation mechanism of cGAS and the function of G3BP1 in the anti-viral immunity. Our results suggest that G3BP1 may be a new target for the treatment of anti-viral and autoimmune diseases.
【学位授予单位】:中国人民解放军军事医学科学院
【学位级别】:博士
【学位授予年份】:2016
【分类号】:R392
【相似文献】
相关期刊论文 前10条
1 舒红兵;;抗病毒天然免疫信号转导关键接头蛋白的发现[J];科学观察;2009年05期
2 ;过氧化物酶体是抗病毒天然免疫的信号转导平台[J];微生物与感染;2011年01期
3 孙辉;蒋争凡;;抗病毒天然免疫研究[J];中国科学:生命科学;2013年10期
4 孙莉;刘殿波;杨宇东;邢雅玲;陈晓娟;陈忠斌;;人类冠状病毒调节宿主抗病毒天然免疫分子机制[J];生物化学与生物物理进展;2010年03期
5 周荣佼;王金燕;王凤;;抗病毒天然免疫识别受体的研究进展[J];中外医疗;2010年34期
6 王平忠;白雪帆;黄长形;王九平;贾战生;姜泓;;Toll样受体介导的抗病毒天然免疫[J];细胞与分子免疫学杂志;2008年05期
7 刘殿波;钱远宇;张七斤;陈忠斌;;抗病毒天然免疫通路中IRF-3调控新机制[J];中国生物化学与分子生物学报;2009年12期
8 刘殿波;孙莉;张百灵;闫飞;陈忠斌;;抗病毒天然免疫反应中RIG-Ⅰ样受体调控机制新进展[J];军事医学科学院院刊;2010年01期
9 秦成峰;秦鄂德;;RIG-I样受体与RNA病毒识别[J];微生物学报;2008年10期
10 何小兵;房永祥;贾怀杰;陈国华;曾爽;景志忠;程国锋;;Toll样受体7介导的抗病毒天然免疫反应研究进展[J];中国兽医科学;2010年06期
相关会议论文 前2条
1 李国勤;卢立志;;动物模式识别受体介导的抗病毒天然免疫作用[A];全国动物生理生化第十一次学术交流会论文摘要汇编[C];2010年
2 蒋争凡;;ERIS-TBK1通路在抗病毒天然免疫中作用的研究[A];免疫细胞生物学热点研究进展——海峡两岸免疫细胞生物学研讨会论文摘要集[C];2013年
相关重要报纸文章 前5条
1 王怀民邋鲁伟;武汉大学在细胞抗病毒天然免疫领域取得重要进展[N];科技日报;2008年
2 记者 蒋明 通讯员 王怀民 鲁伟;细胞抗病毒天然免疫研究有新成果[N];健康报;2008年
3 记者蒋明 通讯员王怀民;细胞抗病毒天然免疫研究获进展[N];健康报;2009年
4 王怀民 记者 赵凤华;我科学家填补病毒核酸信号传导研究一项空白[N];科技日报;2009年
5 整理 蒋明 杨雪;做免疫反应分子机制的探路者[N];健康报;2011年
相关博士学位论文 前6条
1 郑青亮;MicroRNA-27a调控抗病毒天然免疫应答及其机制研究[D];浙江大学;2014年
2 刘朝山;G3BP1通过cGAS调控抗病毒天然免疫的作用机制研究[D];中国人民解放军军事医学科学院;2016年
3 李颖;细胞抗病毒天然免疫信号转导的调控机制[D];武汉大学;2011年
4 徐铮;调控抗病毒天然免疫的miRNA筛选及其作用机制研究[D];华中农业大学;2012年
5 燕杰;E3泛素连接酶TRIM4和TRIM21调节细胞抗病毒天然免疫信号转导的机制[D];武汉大学;2012年
6 顾美娣;蛋白磷酸酶PP1和RAF激酶抑制蛋白RKIP在模式识别受体信号中的调控作用及分子机制[D];浙江大学;2015年
相关硕士学位论文 前1条
1 孙莉;人类新发NL63冠状病毒木瓜样蛋白酶调控宿主抗病毒天然免疫反应及其分子机制[D];中国人民解放军军事医学科学院;2010年
,本文编号:2487227
本文链接:https://www.wllwen.com/yixuelunwen/jichuyixue/2487227.html